Grape King Bio Ltd
Grape King Bio Ltd is a food processing company that produces and sells food products, primarily generating revenue through the sale of its processed food items.
Business. Grape King Bio Ltd (1707.TW) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in Taiwan and is primarily listed on the Taiwan Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Grape King Bio Ltd (1707.TW) is a food processing company operating within the Consumer Non-Cyclicals sector. The firm is headquartered in Taiwan and is primarily listed on the Taiwan Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Grape King Bio Ltd maintains a strong liquidity position, with a current ratio of 1.65 and cash and equivalents amounting to TWD 2,334,573,000. The company's liquidity FPT (free cash flow to total liabilities) is robust, indicating a solid ability to meet short-term obligations. The debt-to-equity ratio is low at 0.02, suggesting minimal leverage and a conservative capital structure.
In terms of profitability, Grape King Bio Ltd demonstrates a return on equity (ROE) of 11.78% and a return on assets (ROA) of 7.74%, both of which are strong indicators of efficient asset utilization and profitability. The company's operating margin is 20.9%, and its net profit margin is 11.9%, which are favorable compared to industry benchmarks.
The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no significant geographic diversification mentioned. This concentration may pose a risk if the segment faces any downturns.
Grape King Bio Ltd has shown consistent revenue growth, with a revenue of TWD 10,251,607,000 in the latest reporting period. The company's outlook for the current fiscal year is positive, with analysts providing a mean price target of TWD 138.00, indicating confidence in its future performance.
The company's risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The dilution potential is also low, and the company has not issued any new shares recently, maintaining a stable capital structure.
Recent events, including analyst estimates and price targets, suggest a positive outlook for Grape King Bio Ltd. The company has received a mean recommendation of 2.00, indicating a "Buy" rating from analysts, with one analyst specifically recommending a "Buy".
- Grape King Bio Ltd has a strong liquidity position with a current ratio of 1.65 and significant cash reserves.
- The company's profitability metrics, including ROE of 11.78% and ROA of 7.74%, are robust and indicate efficient operations.
- The company's revenue is concentrated in a single business segment, which may pose a risk if that segment faces challenges.
- Analysts have a positive outlook for Grape King Bio Ltd, with a mean price target of TWD 138.00 and a "Buy" recommendation.
- The company's low debt-to-equity ratio of 0.02 suggests a conservative capital structure and minimal leverage risk.
- "margin_outlook_rationale": "The company's operating margin of 20.9% and net profit margin of 11.9% indicate strong profitability, which is expected to be maintained due to efficient cost management.",
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 9,88 |
| Revenue | —no estimate | —no estimate | 11,2B TWD |
| Operating income | —no estimate | —no estimate | 2,5B TWD |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- No immediate filing-based liquidity or dilution flags were detected.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Grape King Bio Ltd Market data — financials · 2026-05-26
- Grape King Bio Ltd Market data — analyst estimates · 2026-05-26